1,2-bis(4-diethylaminomethyl-3,5-dioxopiperazin-1-yl)-ethane | 96437-32-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 1,2-bis(4-diethylaminomethyl-3,5-dioxopiperazin-1-yl)-ethane
• 英文别名: 1-(Diethylaminomethyl)-4-[2-[4-(diethylaminomethyl)-3,5-dioxopiperazin-1-yl]ethyl]piperazine-2,6-dione
• CAS: 96437-32-0
• 化学式: C₂₀H₃₆N₆O₄
• 分子量: 424.544
• InChiKey: SOZOYKPOQSDNMC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  30
• 可旋转键数：
  11
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  87.7
• 氢给体数：
  0
• 氢受体数：
  8

反应信息

• 作为产物：
  描述：

  1,2-二(3,5-二氧代哌嗪-1-基)乙烷 、 聚合甲醛 生成 1,2-bis(4-diethylaminomethyl-3,5-dioxopiperazin-1-yl)-ethane
  参考文献：
  名称：

  NIN, YHPO

  摘要：

  DOI：

文献信息

• Bis-dioxopiperazine derivatives, process for their preparation, antitumor agents comprising them and compositions containing them
  申请人：ZENYAKU KOGYO KABUSHIKI KAISHA

  公开号：EP0125475A1

  公开（公告）日：1984-11-21

  Disclosed are novel bis-dioxopiperazine derivatives, process for their preparation, antitumor agents comprising them and compositions containing them. The bis-dioxopiperazine derivatives are represented by the following general formula (I): wherein R, represents a hydrogen atom or a lower alkyl group having 1 to 4 carbon atoms; R2 represents a hydrogen atom or a group of R3 and R., which are respectively independent and are the same or different, represent respectively a lower alkyl group having 1 to 4 carbon atoms, a cycloalkyl group having 3 to 7 carbon atoms or a heterocyclic radical selected from the group consisting of substituted or unsubstituted piperidino, substituted or unsubstituted piperazino, substituted or unsubstituted morpholino and substituted or unsubstituted thiomorpholino, or R3 and R. are bonded together to form a group of which represents a cyclic amino group selected from the group consisting of substituted or unsubstituted pyrrolidino, substituted or unsubstituted piperidino, substituted or unsubstituted piperazino, substituted or unsubstituted morpholino, substituted or unsubstituted thiomorpholino and substituted or unsubstituted thiadiazino; and the substituents of the heterocyclic radical and the cyclic amino group are selected from the group consisting of a lower alkyl group having 1 to 4 carbon atoms, oxo and phenyl, said cyclic amino group being not morpholino when R, is a hydrogen atom and R2 is the group of

  本发明公开了新型双-二氧代哌嗪衍生物、其制备工艺、包含这些衍生物的抗肿瘤药物以及含有这些衍生物的组合物。 双-二氧代哌嗪衍生物由以下通式（I）表示： 其中 R，代表氢原子或具有 1 至 4 个碳原子的低级烷基； R2 代表氢原子或一个由 R3 和 R.组成的基团。 分别独立且相同或不同的 R3 和 R.分别代表具有 1 至 4 个碳原子的低级烷基、具有 3 至 7 个碳原子的环烷基或选自由取代或未取代的哌啶基、取代或未取代的哌嗪基、取代或未取代的吗啉基和取代或未取代的硫代吗啉基组成的组中的杂环基，或 R3 和 R.键合在一起形成一个基团，该基团代表选自由取代或未取代的哌啶基、取代或未取代的哌嗪基、取代或未取代的吗啉基和取代或未取代的硫代吗啉基组成的组中的杂环基。 代表环状氨基，选自由取代或未取代的吡咯烷基、取代或未取代的哌啶基、取代或未取代的哌嗪基、取代或未取代的吗啉基、取代或未取代的噻吗啉基和取代或未取代的噻二嗪基组成的组；杂环基和环状氨基的取代基选自具有 1 至 4 个碳原子的低级烷基、氧代和苯基组成的组，当 R 为氢原子且 R2 为以下基团时，所述环状氨基不是吗啉基
• US4737497A
  申请人：——

  公开号：US4737497A

  公开（公告）日：1988-04-12